Explore the Fingerprint Trends
Explore the Research Network
This is a list of publications by this organization, listed chronologically starting with the most recent first. The source of publications may be a combination of Scopus and manually entered data from a user. New publications from Scopus appear in this list weekly and publications entered by a user appear instantly. Citation counts start from 1996 and come directly from Scopus.
Nathalie A. Kolandijan; Caimiao Wei; Anahit Burke; Agop Y. Bedikian
Malignant melanoma in teenagers and young adults
Dennie T. Frederick; Roberto A. Salas Fragomeni; Aislyn Schalck; Isabel Ferreiro-Neira; Taylor Hoff; Zachary A. Cooper; Rizwan Haq; David J. Panka; Lawrence N. Kwong; Michael A. Davies; et al.
Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics
Kyung Hee Noh; Seok-Ho Kim; Jin Hee Kim; Kwon-Ho Song; Young-Ho Lee; Tae Heung Kang; Hee Dong Han; Anil K. Sood; Joanne Ng; Kwanghee Kim; et al.
API5 Confers Tumoral Immune Escape through FGF2- Dependent Cell Survival Pathway
Li-E Wang; Chunying Li; Ping Xiong; Jeffrey E. Gershenwald; Victor G. Prieto; Madeleine Duvic; Jeffrey E. Lee; Elizabeth A. Grimm; Tao C. Hsu; Qingyi Wei
4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: A case-control analysis
Suk-Won Hwang; Gayoung Park; Chris Edwards; Elise A. Corbin; Seung-Kyun Kang; Huanyu Cheng; Jun-Kyul Song; Jae-Hwan Kim; Sooyoun Yu; Joanne Ng; et al.
Dissolution chemistry and biocompatibility of single-crystalline silicon nanomembranes and associated materials for transient electronics
Geok Choo Sim; Jessica Chacon; Cara Haymaker; Krit Ritthipichai; Manish Singh; Patrick Hwu; Laszlo Radvanyi
Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development
E.R. Plimack; J.R. Desai; J.P. Issa; J. Jelinek; P. Sharma; L.M. Vence; R.L. Bassett; J.L. Ilagan; N.E. Papadopoulos; W.J. Hwu
A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations
Hong Jiang; Karen Clise-Dwyer; Kathryn E. Ruisaard; Xuejun Fan; Weihua Tian; Joy Gumin; Martine L. Lamfers; Anne Kleijn; Frederick F. Lang; Wai-Kwan Alfred Yung; et al.
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model
Kendall C. Shibuya; Vikas K. Goel; Wei Xiong; Jonathan G. Sham; Seth M. Pollack; Allison M. Leahy; Samuel H. Whiting; Matthew M. Yeh; Cassian Yee; Stanley R. Riddell; et al.
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment
Xiao-Hong Ma; Sheng-Fu Piao; Souvik Dey; Quentin McAfee; Giorgos Karakousis; Jessie Villanueva; Lori S. Hart; Samuel Levi; Janice Hu; Gao Zhang; et al.
Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma
Kevin B Kim
PFS as a surrogate for overall survival in metastatic melanoma
Jonathan L. Curry; Carlos A. Torres-Cabala; Kevin B. Kim; Michael T. Tetzlaff; Madeleine Duvic; Kenneth Y. Tsai; David S. Hong; Victor G. Prieto
Dermatologic toxicities to targeted cancer therapy: Shared clinical and histologic adverse skin reactions
Suhendan Ekmekcioglu; Razelle Kurzrock; Elizabeth A. Grimm
Hematopoietic Growth Factors and Cytokines
Patrick Hwu; Gregory Lizée; Yong-Jun Liu
Cancer and the Cellular Immune Response
Esther Lopez-Rivera; Padmini Jayaraman; Falguni Parikh; Michael A. Davies; Suhendan Ekmekcioglu; Sudeh Izadmehr; Denái R. Milton; Jerry E. Chipuk; Elizabeth A. Grimm; Yeriel Estrada; et al.
Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2
Chandrani Chattopadhyay; Elizabeth A. Grimm; Scott E. Woodman
Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration
Todd D. Prickett; Brad Zerlanko; Jared J. Gartner; Stephen C. J. Parker; Ken Dutton-Regester; Jimmy C. Lin; Jamie K. Teer; Xiaomu Wei; Jiji Jiang; Guo Chen; et al.
Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin
Amanda D. Bucheit; Michael A. Davies
Emerging insights into resistance to BRAF inhibitors in melanoma
Bonggoo Park; Cassian Yee; Kyung-Mi Lee
The effect of radiation on the immune response to cancers
Geok Choo Sim; Natalia Martin-Orozco; Lei Jin; Yan Yang; Sheng Wu; Edwina Washington; Deborah Sanders; Carol Lacey; Yijun Wang; Luis Vence; et al.
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients